About
Olipass develops advanced RNA therapeutic technologies based on Peptide Nucleic Acid (PNA) derivatives that enable improved cell permeability and exon skipping to create novel drug candidates for safe and effective treatments.
Explore Olipass's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.